L
Lytix Biopharma AS
OSE:LYTIX
Lytix Biopharma AS
OSE:LYTIX
Price:
9.36
NOK
-1.27%
Market Cap:
638.9m
NOK
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-5.8
Current
-2.7
Median
4.4
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-5.8
Enterprise Value
/
523m NOK
EBITDA
-89.7m NOK
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
-36.1
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A
You don't have any saved screeners yet
